RENAISSANCE TECHNOLOGIES LLC
Position in ACHV — Achieve Life Sciences, Inc.
CIK 1037389
NEW YORK, NY
Position in ACHV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,162,659
+$1,080,481 QoQ
Shares Held
178,049
+537.0% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 111 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ACHV ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ACHV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,162,659 | 178,049 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $82,178 | 27,952 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $757,726 | 152,460 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $978,906 | 310,764 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $234,655 | 87,886 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $215,283 | 61,160 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $169,976 | 35,860 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $117,782 | 25,060 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $48,685 | 10,700 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $44,908 | 10,900 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $95,030 | 22,100 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $205,524 | 39,600 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $282,880 | 41,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $96,040 | 39,200 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $127,710 | 38,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $193,736 | 39,700 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $190,764 | 25,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $185,164 | 23,800 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $192,100 | 22,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $691,100 | 76,960 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $255,466 | 22,061 | Shares | Sole | 2021-05-13 | |
| 2020-06-30 | $199,692 | 499,230 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $235,320 | 713,091 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||